Capital Research Global Investors Ideaya Biosciences, Inc. Transaction History
Capital Research Global Investors
- $479 Billion
- Q2 2025
A detailed history of Capital Research Global Investors transactions in Ideaya Biosciences, Inc. stock. As of the latest transaction made, Capital Research Global Investors holds 6,552,691 shares of IDYA stock, worth $155 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
6,552,691
Previous 2,734,923
139.59%
Holding current value
$155 Million
Previous $44.8 Million
207.46%
% of portfolio
0.03%
Previous 0.01%
Shares
8 transactions
Others Institutions Holding IDYA
# of Institutions
218Shares Held
83.4MCall Options Held
28.7KPut Options Held
132K-
Black Rock Inc. New York, NY6.81MShares$161 Million0.01% of portfolio
-
Janus Henderson Group PLC London, X06.21MShares$146 Million0.07% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct5.03MShares$119 Million0.24% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.94MShares$117 Million0.0% of portfolio
-
Federated Hermes, Inc. Pittsburgh, PA4.63MShares$109 Million0.19% of portfolio
About IDEAYA Biosciences, Inc.
- Ticker IDYA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 48,067,700
- Market Cap $1.13B
- Description
- IDEAYA Biosciences, Inc., a synthetic lethality-focused precision medicine oncology company, focuses on the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. The company's lead product candidates include IDE397, a methionine adenosyltransferase 2a inhibitor that is in Phase I clinica...